PDCD1 and melanoma: In a recent study, it was demonstrated that in murine B16 melanomas, the stable NRF2 silencing by a specific shRNA knockdown induces the PD-1/PD-L1 inhibition to activate infiltration T cells and the reduction of melanoma growth [158].